AccuSift provides high-performance Lomefloxacin competitive assay pairings, characterized by exceptional batch-to-batch consistency and optimized for IVD kit development (Lateral Flow, Chemiluminescence, ELISA, POCT). These pairings offer high affinity and specificity, facilitating rapid detection.Lomefloxacin is primarily effective against urinary tract, respiratory tract, and intestinal infections. It is a long-acting oral fluoroquinolone antibacterial agent. It exerts its antibacterial effect by inhibiting bacterial DNA gyrase, thereby halting bacterial growth. It features a broad antibacterial spectrum, high efficacy, safety, metabolic stability, and good tolerability. Because it has no cross-reaction with theophylline, there are no contraindications for concurrent use in asthma patients, making it particularly suitable for the elderly. It can be used for respiratory infections, sepsis, enteritis, urinary tract infections, gynecological infections, eye and oral infections, and for postoperative infection prevention.
•Sensitivity: ELISA IC50: 0.2 ppb
•Cross-Reactivity: Sparfloxacin 0.2 ppb
•Sensitivity: ELISA IC50: 0.2 ppb
•Source: Mouse Monoclonal Antibody
•Purity: ≥ 90%
•Recommended Pairing: (Coating) / (Labeling)
•Storage: Long-term storage at ≤ -20°C; short-term storage at 2-8°C. Shipped on ice packs.
WeChat
